Hosted on MSN25m
Hims & Hers Retail Traders Eye Robust Post-Earnings Rebound Following Stock’s Worst Drop On Semaglutide Update
Hims & Hers Health Inc. (HIMS) stock tumbled over 25% on Friday, extending losses in after-hours trading after the U.S. Food ...
NEA Baptist becomes first in Arkansas to implant new heart failure device
JONESBORO, Ark. (KAIT) - One Northeast Arkansas hospital became the first in the state to successfully implant a new heart ...
Zydus Lifesciences, Granules, Glenmark: Nifty Pharma up despite weak market
Zydus Lifesciences: The company and its subsidiaries received final approval from the United States Food and Drug Administration (US FDA) to manufacture Ibuprofen and Famotidine tablets, 800 mg/26.6 ...
中国日报网52m
Chinese and ASEAN scholars share insights on ASEAN-China relations
The High-Level Think Tank Seminar on ASEAN-China Relations, themed "Navigating the Future of ASEAN-China Relations: ...